CI Investments Inc
VNDA icon

CI Investments Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

CI Investments Inc’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,421
Closed -$107K – 1422
2022
Q1 		$107K Buy
+9,421
New +$124K ﹤0.01% 847
2021
Q3 		– Sell
-14,193
Closed -$305K – 1406
2021
Q2 		$305K Buy
+14,193
New +$254K ﹤0.01% 683

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CI Investments Inc's VNDA Position: Q2 2022 in Review

CI Investments Inc sold out of Vanda Pharmaceuticals (VNDA) in Q2 2022, closing a stake of 9,421 shares — an estimated $107K sold.

CI Investments Inc first reported a position in VNDA in Q2 2021 and held it in 2 quarters. The position peaked at $305K in Q2 2021. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2022.

  • CI Investments Inc reported no remaining Vanda Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • CI Investments Inc sold 9,421 Vanda Pharmaceuticals shares in Q2 2022, an estimated $107K.
  • CI Investments Inc first reported a position in Vanda Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • CI Investments Inc's Vanda Pharmaceuticals position peaked at $305K in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.